Acadia Pharmaceuticals Soars 9% on S&P 600 Addition, Don't Buy the Stock!

ACADIA Pharmaceutical (ACAD) shares are closing out the year on a strong note rising more than 9% on Tuesday on heavy volume.  The stock’s heavy...

Pages 1 of 1